BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11698130)

  • 1. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.
    Miller CB; Rowlings PA; Zhang MJ; Jones RJ; Piantadosi S; Keating A; Armitage JO; Calderwood S; Harris RE; Klein JP; Lazarus HM; Linker CA; Sobocinski KA; Weisdorf D; Horowitz MM
    Exp Hematol; 2001 Nov; 29(11):1336-46. PubMed ID: 11698130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience.
    Smith BD; Jones RJ; Lee SM; Piantadosi S; Vala MS; Fuller D; Gore SD; Noga SJ; O'Donnell PV; Braine H; Vogelsang GB; Fuchs EJ; Flinn IW; Brodsky RA; Ambinder RF; Miller CB
    Br J Haematol; 2002 Jun; 117(4):907-13. PubMed ID: 12060130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.
    Demirer T; Gooley T; Buckner CD; Petersen FB; Lilleby K; Rowley S; Sanders J; Storb R; Appelbaum FR; Bensinger WI
    Bone Marrow Transplant; 1995 Jun; 15(6):907-13. PubMed ID: 7581090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institution.
    Gorin NC; Labopin M; Laporte JP; Douay L; Lopez M; Lesage S; Fouillard L; Isnard F; Jouet JP; Bellal N; Perot C; Van Den Akker J; Bauters F; Najman A
    Exp Hematol; 1999 Dec; 27(12):1822-30. PubMed ID: 10641600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission.
    Lenarsky C; Weinberg K; Petersen J; Nolta J; Brooks J; Annett G; Kohn D; Parkman R
    Bone Marrow Transplant; 1990 Dec; 6(6):425-9. PubMed ID: 2097012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report.
    Linker CA; Ries CA; Damon LE; Rugo HS; Wolf JL
    Bone Marrow Transplant; 1998 Nov; 22(9):865-72. PubMed ID: 9827814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia.
    Demirer T; Petersen FB; Bensinger WI; Appelbaum FR; Fefer A; Rowley S; Sanders J; Chauncey T; Storb R; Lilleby K; Buckner CD
    Bone Marrow Transplant; 1996 Jul; 18(1):29-34. PubMed ID: 8831992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia.
    Rizzieri DA; Talbot JT; Long GD; Vredenburgh JJ; Gasparetto C; Smith CS; Colvin MO; Adams D; Morris A; Dodge R; Loftis J; Waters-Pick B; Reese M; Carawan H; Koh LP; Chao NJ
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):183-8. PubMed ID: 12652469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations.
    Yeager AM; Rowley SD; Kaizer H; Santos GW
    Am J Pediatr Hematol Oncol; 1990; 12(3):245-56. PubMed ID: 2240470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia.
    Dusenbery KE; Daniels KA; McClure JS; McGlave PB; Ramsay NK; Blazar BR; Neglia JP; Kersey JH; Woods WG
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):119-28. PubMed ID: 7995742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
    Demirer T; Buckner CD; Appelbaum FR; Petersen FB; Rowley S; Weaver CH; Lilleby K; Sanders J; Chauncey T; Storb R
    Bone Marrow Transplant; 1995 Jun; 15(6):915-22. PubMed ID: 7581091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
    Damon LE; Rugo HS; Ries CA; Linker CA
    Bone Marrow Transplant; 1996 Jan; 17(1):93-9. PubMed ID: 8673063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome.
    Woolfrey AE; Gooley TA; Sievers EL; Milner LA; Andrews RG; Walters M; Hoffmeister P; Hansen JA; Anasetti C; Bryant E; Appelbaum FR; Sanders JE
    Blood; 1998 Nov; 92(10):3546-56. PubMed ID: 9808546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
    Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E
    Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.
    Mehta J; Powles R; Singhal S; Horton C; Tait D; Treleaven J
    Bone Marrow Transplant; 1996 Jul; 18(1):119-23. PubMed ID: 8832004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with lymphoid malignancies transplanted with unpurged or adjusted-dose mafosfamide-purged autologous marrow.
    Carlo-Stella C; Mangoni L; Almici C; Cottafavi L; Meloni G; Mandelli F; Rizzoli V
    Blood; 1992 Nov; 80(9):2412-8. PubMed ID: 1421413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis.
    Reiffers J; Labopin M; Sanz M; Korbling M; Blaise D; De La Rubia J; Gorin NC
    Bone Marrow Transplant; 2000 Jun; 25(11):1115-9. PubMed ID: 10849522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purging with 4-hydroperoxycyclophosphamide.
    Jones RJ
    J Hematother; 1992; 1(4):343-8. PubMed ID: 1345676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up.
    Ball ED; Wilson J; Phelps V; Neudorf S
    Bone Marrow Transplant; 2000 Apr; 25(8):823-9. PubMed ID: 10808202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous bone marrow transplantation in acute myeloid leukemia: the University of Minnesota experience.
    Dusenbery KE; Steinbuch M; McGlave PB; Ramsay NK; Blazar BR; Neglia JP; Litz C; Kersey JH; Woods WG
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):335-43. PubMed ID: 8892457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.